ESC 2023 Update: 12 months of anticoagulation improves outcomes in cancer patients with minor blood clots Dr. Kamal Kant Kohli29 Aug 2023 11:45 AM ISTTwelve months of edoxaban is superior to three months for the reduction of thrombotic events in patients with cancer and distal deep vein thrombosis ...
ESC 2023 Update: Traditional Chinese medicine qiliqiangxin shows meaningful clinical benefits in patients with HF Dr. Kamal Kant Kohli29 Aug 2023 9:45 AM ISTChina: A recent study has supported the role of the traditional Chinese medicine qiliqiangxin as an adjunct therapy for treating heart failure. The...
ESC 2023 Update: Presence of three or more unhealthy traits tied to earlier heart attack and stroke in middle-aged adults Dr. Kamal Kant Kohli29 Aug 2023 9:00 AM ISTSweden: People in their 40s and 50s having three or more unhealthy traits including high blood pressure, waist circumference, glucose, and cholesterol...
ESC 2023 Update: Extended P2Y12 inhibitor monotherapy benefits high-risk acute coronary syndrome patients Dr. Kamal Kant Kohli29 Aug 2023 8:45 AM IST Extended P2Y12 inhibitor monotherapy beyond 12 months after percutaneous coronary intervention (PCI) reduces bleeding and ischaemic events in acute ...
ESC Congress Guideline Update 2023: Important Highlights Isra Zaman28 Aug 2023 11:45 AM ISTImportant guideline updates have been released from the ESC congress 2023 held in Amsterdam between 25-28th August 2023. Here are important snippets...
ESC 2023 Updates Guideline for Managing Cardiovascular Disease in Diabetes Dr. Prem Aggarwal28 Aug 2023 11:15 AM ISTThe European Society of Cardiology (ESC) released Guidelines for Managing Cardiovascular Disease in Patients with Diabetes, 2023.The guideline,...
ESC 2023 Update: Iron therapy tied to reduced hospitalization, CV death in iron-deficient heart failure patients: Study Dr. Kamal Kant Kohli28 Aug 2023 10:45 AM ISTPoland: A recent study has suggested considering intravenous ferric carboxymaltose (FCM) in iron-deficient patients with heart failure and reduced or...
ESC 2023 Update: Colchicine does not reduce primary outcomes in patients undergoing major non-cardiac thoracic surgery: COP-AF trial Dr. Kamal Kant Kohli28 Aug 2023 10:30 AM ISTCanada: In patients undergoing major non-cardiac thoracic surgery, colchicine fails to significantly reduce perioperative atrial fibrillation (AF) or...
ESC 2023 Update: Optical coherence tomography for stent insertion in complex cases shows mixed efficacy Dr. Kamal Kant Kohli28 Aug 2023 10:15 AM ISTOptical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) leads to a larger minimum stent area but does not reduce the...
Management of Heart Failure: ESC Updates Guidelines Dr. Kamal Kant Kohli28 Aug 2023 10:00 AM ISTCanada: The European Society of Cardiology (ESC) has taken a significant stride in the field of heart failure management with a focused update to...
ESC 2023 Update: First ESC Guidelines covering all acute coronary syndromes Dr. Kamal Kant Kohli28 Aug 2023 10:00 AM ISTThe European Society of Cardiology (ESC) Guidelines on acute coronary syndromes are published online today in European Heart Journal.1 The document ...
ESC 2023 Update: Dual-antiplatelet therapy should remain standard strategy after stent implantation Dr. Kamal Kant Kohli28 Aug 2023 9:45 AM ISTPrasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not superior to dual-antiplatelet therapy (DAPT) for...
